Gregory L. Weaver, EVP & CFO at ATOSSA THERAPEUTICS, INC. (ATOS), bought 50,000 shares at $0.97 ($49K) on 2023-06-20, disclosed to the SEC on 2023-06-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ALT | BUY | 2025-03-14 | $52K | — | Filing → |
| ATOS | SELL | 2023-11-17 | $33K | — | Filing → |
| ATOS | SELL | 2021-07-07 | $1.2M | — | Filing → |